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INTRODUCTION
Constipation is a symptom that frequently complained
by patient in clinical practice, but most of the time it is not
taken seriously by physicians. This happens because it is
more considered as complaint than a ‘disease’ so that it
was taken for granted many times. More attention will be
given if there has already been  a complication or
anorectal abnormality such as anal fissure and
hemorrhoid.
Back to the old Egyptian period, constipation was
explained as autointoxication concept of the body
isolated substance from toxic in the gastrointestinal tract.1
This was proven after the physician had successfully
isolated ‘substance’ from fecal mass in the gastro-
intestinal tract and injected it to animal model and then it
was found toxic and dangerous. This had been a basic
concept that the substance could be absorbed into blood
circulation. Until the early 20th century the concept of
autointoxication had been discussed in many lectures.
In addition, constipation was considered as the cause of
about 90% of diseases and had poor prognosis.1 This had
implication in the management of constipation. Laxatives
agents have been used frequently and in general
population, people tend to buy and use it by themselves
whenever they think they have constipation.
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ABSTRACT
Constipation is the most ignored complaint by doctors and unfortunately, it requires urgent
management due to the decreased quality of life. Most cases are functional constipation but there is also
a great number of constipation due to organic abnormalities. In an attempt to manage the patient properly, we
should put our emphasis on excellent knowledge of pathophysiology of constipation.By using the colonic
transit time test, we could determine the type of constipation, which would have an effect on therapy. In most
cases, constipation has a good response to high fiber diet and additional laxative medication and surgical
therapy is seldom required unless complications have occurred. There is also a suggestion for preventing
constipation may be caused by opioid usage.
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In the western countries, constipation has become
common problem and accounted 2% - 27% of general
population. In the US, visiting doctor rate due to
constipation had reach 2.5 million per year and about
92,000 cases needed hospitalized.2 Constipation was found
more in women than in men with ratio of 3:1. Risk factors
of constipation are less physical activity, low education,
history of sexual abuse and depression. Constipation may
occur in all ages and the highest incidence is 30% - 40% in
group of age beyond 65 years old.3 This might due to
changing pattern of diets, decreased muscle tonus, and
drug consumption that cause dehydration or colonic
dysmotility.
In Western countries, constipation problem have  been
reported more in black population than Asians and
Caucasians. However, if Asian people have the Western
style of diet which contains low fiber, they will have
symptom of constipation.
DEFINITION
Constipation is not easy to define, thus, there is no one
single definition of it.2 Most patients describe
constipation by the presence of one or more symptoms of
hard stool, irregular defecation (usually less than 3 times
per week), excessive straining during defecation, sense
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of incomplete evacuation of the rectum and much time
spent for defecation. Regarding all things above, in
general, constipation can be defined as frequency of
defecation 2 times or less per week or excessive straining
while defecation.  From several studies, it was concluded
that normal frequency of defecation was 5 times per week
and could varied according to gender and age. There was
some opinion of normal frequency of defecation 3 to 12
times per week. For scientific research, criteria used for
constipation was according to Roman II criteria as
follows:2
• In adult if it is found two or more of the following
criterias mentioned below and have been gone for at
least 12 weeks (not necessary to be subsequent) in
the last 12 months there are excessive straining or at
least 25% of all defecations; softened ort hard stool in
more than 25% defecation; incomplete  evacuation of
stool in more than 25% of  defecations; the presence
of anorectal inhibition in more than 25% of
defecations; the necessity of hand maneuver to
facilitate defecation in more than 25% of defecations;
frequency of defecations less than 3 times per week;
there is no liquid stool found and symptoms mimicking
irritable bowel syndrome
• In babies and children,  stool predominantly hard and
small in most of defecations for at least 2 weeks and
there is no structural, endocrinologic or metabolic
disorders
Definite etiology of constipation is difficult to be
determined because it is multifactorial and maybe caused
by systemic disease, neurologic disorders or drugs.
The most frequent cause of constipation nowadays is
improper eating habit, structural abnormalities and
systemic diseases. Diet pattern that leads to
constipation is lack of fiber and fluid especially in
elderly.4 In severe and refractory constipation which is
usually caused by colonic inertia (delayed colon transit)
and abnormalities in rectum and pelvic floor. On the other
hand, decreased activity may cause constipation. This was
based on the fact that the active people who had no
constipation before turned to have it when they were not
physically active anymore. Most of people have it are the
ones who are bedridden or chairbound.4 Some drugs may
also induce constipation. Some drugs that had been
reported are calcium-containing antacid, iron
supplementation, anti diarrhea, and opioid drugs.
PATHOPHYSIOLOGY
To date, constipation is classified into 3 categories as
follows constipation with normal transit time, delayed
transit time and defecatory disorders or rectal
evacuation abnormalities.2 This classification is based on
observation in 1,000 patients with chronic constipation.
Further more, it found that constipation with normal   transit
time was the most frequent cause followed by defecatory
disorder, constipation with delayed transit time and
combination of both defecatory disorder and delayed transit
time.
Constipation with normal transit time (usually is called
functional constipation), the patient has disturbance on stool
evacuation or the presence of hard stool. There are no
abnormalities in fecal movement in the colon. Patient
complains of bloating and abdominal pain and sometimes
accompanied by psychosocial problems. Other patient may
complain of increased resistance or rectal sensitization
while defecation or the combination of these two. These
symptoms usually are responsive to treatment of high
fiber diet or laxative agent. If there was lack of response
to therapy, it needs to give additional therapy.
Constipation with delayed transit time has delayed
movement of colonic peristaltic (less than once a week).
This abnormality is often seen in young women and
usually in puberty period. Symptoms commonly found are
urgency and irregular defecation time, bloating and
abdominal pain. Patient with this kind of disorder have
delayed transit in proximal colon and decreased
peristaltic contraction. This also have differences in grade
of severity. In mild abnormalities, might be caused by low
fiber diet and culture factor. Increase in fiber contain in
daily diet can increase fecal mass, reduce colonic transit
time, and diminish symptom of constipation. In patient with
severe abnormalities, additional fiber and laxative agents
may give sufficient response. Histopathologic
examination reveales changes in some of neuronal plexus
myentericus which responsible for neurotransmitter
excitation of P substance. Other disorder is inhibitory
defect on VIP neurotransmitter and nitrite oxide and
decreased number of cajal cells which responsible of
gastrointestinal tract motility. Hirschprung disease is an
extreme example of this disorder.
Other type of constipation is defecatory disorders; in
which there are abnormalities in pelvic floor or anal
sphincter. Other term used to describe it was anismus,
pelvic floor dysinergia, pelvic floor paradoxal
contraction, obstructive constipation, functional
rectosigmoid obstruction, pelvic floor spasm syndrome and
functional fecal retention (in childhood). This kind of
disorder may be caused by habit of postponing
defecation because they want to avoid the pain while
defecation. This pain is associated with fecal consistency
and big volume or the presence of anal fissure or
hemorrhoid. Other rare causes of structural disease are
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rectal intussusceptions, rectocele, sigmoidocele
obstruction, and perineal collapse.
In elderly, constipation is influenced by internal
factors (associated with increasing age) and external
factors. Internal factors include delayed transit time,
neurologic disorders (in myentericus plexus involve
neuropeptide receptor), aging associated functional
disorder like decreased tonus of rectum and anus.
External factors include restricted activity, drug
adverse effect, neurologic disorder, metabolic
disorder, dehydration, low fiber intake, obstruction
caused by tumor.5
Long term use of opioid drugs along with tricyclic
antidepressant, anticonvulsant and psychotropic drugs
often induces constipation.15 Usually it can be anticipated
and avoided before worsening. However, most of the time
the symptoms are not treated aggressively so it will
disturb the patient. The following feature when the opioid
drugs have been stopped then pain will reoccur.
Constipation induced by opioid occurs through 2 (two)
kinds of mechanisms. First, direct effect of opioid to slower
GI tract peristaltic so that fluid absorption will increase
and cause hard stool and induce fecal impaction. Second
cause is the presence of abundant opioid receptor GI
system which makes decreased motility and tonus while
resting and induce spasm.
Constipation may be found in pregnant women,
although they have no history of constipation before.
Patients who had constipation and then got pregnant will
have worsening symptom on constipation. The incidence
was varied start from 11% to 35% in third semester
pregnancy. This was believed as consequence of
physiologic changes during pregnancy. Intestinal
motility is decreased during pregnancy and will cause
exacerbation of previously gastrointestinal tract
abnormalities. Research data showed progesterone will
decrease smooth muscle and contractility as well as
delayed transit time.7
Beside hormonal factors, others that influence
constipation in pregnancy are lack on fluid and fiber
intake, iron supplementation, decreased physical
activity, psychosocial stress, stress fro, uterine
enlargement, hemorrhoid that cause pain (in some
patients).
DIAGNOSIS
Careful history taking and a thorough physical
examination are aimed to exclude the secondary causes
of constipation since it is usually chronic symptom.
Anamnesis will give valuable data on lifestyle changes
related to the onset of constipation. Fecal consistency may
give clues to predict colonic transit time with
assumption that liquid stool is correlated to fast transit
time, while hard and solid stool is correlated with
delayed transit time.
Physical examination is important to assess
abnormality in rectum, start from perianal area
(the presence of fissure, fistula and hemorrhoid). Next
examination is perineal area at rest and supine position to
determine the extent of perineal descent (normal range is
1 to 3.5 cm). Perineal descent less than 1 cm indicates
failure of pelvic floor muscle to relax while defecation.
On the other hand, if descent is more than 3.5 cm, it
indicates the presence of perineal rigidity possibly caused
by excessive straining while defecation and has been gone
for long time (from childhood) resulting in incomplete  fecal
evacuation. Further more, excessive straining of pelvic
floor will impair the nerves in sacrum area and decrease
sense for complete evacuation of the rectum and finally
cause fecal incontinence. Physical examination also
includes digital rectal examination to search for anal
stricture, rectal mass, assess tone and strength of the anal
canal at rest and with squeeze, or detect the presence of
fecal impaction.
Next step, supporting examinations will be performed
to search for the presence of systemic disease or local
abnormalities that can cause constipation. Complete
laboratory examinations include peripheral blood
examination, electrolyte, blood glucose, calcium level,
urinalysis, and thyroid function test. Colonoscopy and
barium enema will be beneficial in search for local
abnormalities. They are aimed to detect the possibility of
colorectal malignancy since constipation may be the early
symptom of it.
In patient with symptom of refractory constipation
(no secondary causes of constipation have been found)
or lack of response to high fiber diet and laxative agents,
it is an indication to perform physiologic test as follows:
• Colonic transit studies: aimed to assess colonic
movement time. Normal time duration is 72 hours
• Anorectal manometry test, aimed to assess anal
sphincter pressure (specially internal anal sphincter)
in relaxation, maximal contraction of external anal
sphincter, the presence of anorectal inhibitory reflex,
rectal sensitivity and the ability anal sphincter to
relax while straining
• Balloon expulsion test as screening test for disorders
in defecatory process
• Defecography aimed to assess rectal evacuation,
anorectal angle, perineal descent, structural diseases
that may influence defecation such as rectocele,
mucosal prolapse, or intussusceptions
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TREATMENT
Treatment depends on types of constipation and any
factors that may have role in inducing it. It is also
necessary to educate the patients about treatment
strategies and importance of fiber intake, regular
defecation and avoidance of excessive use of laxative
drugs for long term treatment. Treatment of
constipation usually begins with high natural fiber (from
fruits and vegetables) or synthetic fiber intake.2 If it is
considered lack of response, we may start to use
laxative agents or additional prokinetic drugs such as
tegaserod. Surgical intervention is rarely performed.
Patients with defecatory process disorder are
usually unresponsive to laxative drugs, except if it is given
in much larger dose. However, large dose of laxative agent
may cause diarrhea. That is why patient needs to have
biofeedback therapy.8 On the other hand, in
patients with fecal impaction, it is very important to
evacuate the impacted feces manually or with enema.
Fecal impaction should be prevented by adding fiber
intake and proportional use of laxative drugs to induce
regular defecation.
Fiber supplementation
Fiber supplementation is the early treatment of
constipation especially in cases of suspected functional
constipation. Additional fiber consumption of 20-30 g/day
usually will help much. The presence of fecal
impaction needs to exclude first before begin fiber
supplementation treatment. Fiber supplementation
consists of 2 kinds of fiber:
• Natural fiber: 1 to 2 spoons of natural fiber mixed
with water or food is relatively inexpensive and
provides 10 - 20 g fiber per day. Disadvantage is gas
formation in the gastrointestinal tract.
• Medical supplements: various synthetic fiber
supplementations are available in the market recently
with various kinds of taste and interesting forms such
as tablets or cake. The advantage is lack of gas
formation in gastrointestinal tract. Most contain  3.4 g
of psyllium and 2 g of cellulose methyl form from
plants and 1 g of polycarbofill (synthetic fiber).
Laxatives
• Osmotic laxatives are frequently used to soften
the stool. They may be given as single treatment or in
combination with fiber supplementation. They are
mostly used in hospitalized elderly patients to
prevent constipation and fecal impaction. These drugs
are safe to be used chronically and had no addictive
effect. Doses will be given may be titrated to form
softened or liquid stool.
• Bulking agents consist of natural polysaccharide (psyl-
lium) or synthetic or cellulose derivatives which have
the same mechanism as the natural fiber in food. They
should be given with relatively much amount of wa-
ter. Thus, it should be cautiously given for patient with
water restriction. Laxative containing aspartame
(nutrasweet) is contraindicated in patient with
phenylketonuria.
• Emollient laxatives consist of mineral oil and
decussate salts. Mineral oil can be given orally or by
enema; it penetrates and softens the stool. Because
mineral oil may decrease the absorption of fat-soluble
vitamins A, D, and K, it should be administered
between meals. Aspiration with lipid pneumonia is well
described; therefore, mineral oil is contraindicated in
patients with esophageal dysmotility or dysphagia and
in elderly or debilitated patients and should not be given
at bedtime.
• Saline laxatives contain relatively no absorbable
cations and anions that exert an osmotic effect to
increase intralumenal water content. Magnesium
may also stimulate the release of cholecytokinin to
increase intestinal motor activity. Because an
appreciable amount of magnesium may be
absorbed, it should be avoided in patients with
renal insufficiency because of the danger of
magnesium toxicity.
• Stimulant laxatives consist of castor oil,
anthraquinones (cascara sagrada, senna, casanthranol,
and danthron), and diphenylmethanes
(phenolphthalein and bisacodyl). Castor oil is
hydrolyzed by intestinal lipases to ricinoleic acid, which
stimulates intestinal secretion, decreases glucose
absorption, and increases intestinal motility.
• Hyperosmolar agents include mixed electrolyte
solutions containing polyethylene glycol and
nonabsorbable sugars such as lactulose and sorbitol.
Sorbitol and lactulose are degraded by colonic
bacteria to low-molecular-weight acids that increase
stool acidity and osmolarity. Doses should be adjusted
to reduce side effects and modulate defecation.
Sorbitol and glycerin are given intrarectally and may
produce rectal irritation. Polyethylene glycol
solutions are most often given for bowel cleansing
before colonoscopy or before institution of bowel
programs.
Prokinetic Drugs
Tegaserod is a new colonic prokinetic agent.  This drug
is a partial [5-hypoxytryptamine (5-HT)] agonists which
can increased stool consistency and frequency of
defecation. It is used frequently for  irritable bowel
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syndrome with constipation predominant. It may also be
given in severe refractory constipation who unresponsive
to fiber supplementation or osmoticlaxatives.
Biofeedback therapy 2,8,9,10
Biofeedback therapy is used to exercise the patients
for pelvic floor relaxation while straining during
defecation. This includes coordination with abdominal
maneuver to strengthen fecal movement to the rectum.
Successful rate with this therapy was reported
achieving 67% and beneficial effect may last longer.
However, it is useless in patients with perineal descent.
Biofeedback therapy is beneficial for patients with
pelvic muscle contraction disorder (dyssinergia).
Botulinum toxin type A
Injection of botulinum toxin type A into puborectal
muscle was believed to be effective in treatment of
constipation, especially for defecatory disorders which
involve pelvic floor muscle spasm. However, it is not
recommended because there has not been any controlled
trial yet to prove it.
Surgical therapy
In refractory constipation, it is an indication for total
colon resection and ileorectostomy if there is no defecatory
disorder. This surgical intervention is performed after
pharmacologic treatment considered ineffective. General
complications are diarrhea and incontinence which is
usually last for 1 year. Patients with underlying pshycologic
disorder should not be candidate for this treatment
because it will not give much improvement. Rectal
surgery may be performed in patients with rectocele or
female patients who always need to press their vagina to
facilitate defecation.
Beside all those kinds of therapy mentioned above,
recently it has been found new class of drug called
chloride canal activator.11 From clinical trial with
128 subjects with constipation, it revealed satisfactory
result in 4 weeks. The management of constipation in
elderly actually is not much different from the young adult
patients. However, it should be noted the complications
may become more serious in elderly patients.
Complications may arise from excessive straining, fecal
incontinence, fecal impaction, stercoral perforation,
urinary retention, sigmoidal volvulus, rectal prolapse and
all will finally cause decreased quality of life.
Physiological disturbance may occur in form of
depression, increased dependency and restrain from
social environment. This happens because constipation is
seldom complained by elderly patients and is frequently
under diagnosed and under treated. One thing should be
noted is that using laxative agents may not be effective
for prevention of constipation in elderly patients.4
Management of constipation due to opioid drugs is better
beginning with bowel clean out which is aimed to prevent
fecal impaction. Further management is directed to
prevent constipation. It usually uses stimulant laxative and
stool emollient beside fiber supplementation and
increased fluid intake. These aimed to induce fecal mass
formation, prevent excessive fluid absorption, and
stimulate colonic contraction for defecation. It will be much
better if we can reduce the dose of opioid drugs but it will
not be comfortable for the patients because of the pain.
In several cases, some may give cisapride to stimulate
colonic contraction, especially if it was unresponsive to
previous pharmacologic treatment. However, cisapride
had not been used widely considering its cardiovascular
effect that may arise. The use of opioid antagonist
(naloxon) has also been considered to minimize the effect
of opioid drugs but the efficacy is still controversial.
It should be well-informed to patients not to use large
amount of synthetic laxative agents because they may
cause abdominal bloating and flatulence which are very
uncomfortable for the patients.
COMPLICATIONS
1. Hemorrhoid
The occurrence of hemorrhoid is due to increased
venous pressure in pelvic areas. Degeneration process in
structural tissues in anal sphincter (due to aging
process or other) causes hemorroidal protrusion and
descent toward the anus. Management of hemorrhoid is
varied from local pharmacologic treatment to surgical
intervention depends on severity of hemorrhoid.12
2. Anal fissure
It is an injury in the canalis annulus and usually very
painful. This caused by trauma due to hard stool
passage and excessive straining during defecation
resulting injury in posterior canalis annulus. This part has
relatively thin layer of muscle tissues so that it is easily
injured. It is already indication to perform surgery if there
is anal fissure because it is predisposing factor for
infection.12
3. Proctitis
Proctitis is inflammatory condition limited to rectal area
caused by hard stool or excessive straining during
defecation. Proctitis may also involve bacterial
infection. To confirm diagnosis of proctitis, it should
perform biopsy of the rectal tissue.12
4. Malignancy
Malignancy is indirect complication of constipation.
Prolonged colonic transit time causes prolonged contact
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of colonic mucosa with various substances in feces
specially bile acid. An observational study had revealed
higher level of bile in the feces in group of patients with
colon cancer compare to other groups.13
CONCLUSION
Constipation should be managed seriously because it
may decrease quality of life. Factors that may induce
constipation must be identified for proper management.
Self- treatment by using laxative agents should be
well-controlled to prevent any unwanted side effects.
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